MedMira, Inc. (CVE:MIR) | WebDisclosure

Basculer en Français

11088	Companies
243618	Keywords
171758	Articles
131230	Press releases

Home
Companies
MedMira, Inc.

PRESS RELEASE

published on 02/01/2024 at 13:35, 2 years 7 months ago

Corporate Update on Clinical Evaluation of MedMira’s Products
MedMira Inc. provides update on Health Canada review process for maternity screening, highlighting increasing need due to rising syphilis infection rates. Company's syphilis test performance shows promising results for infectious case detection and maternity screening

MedMira Inc. Health Canada Review Maternity Screening Syphilis Infection Rates Test Performance
PRESS RELEASE

published on 12/30/2023 at 05:00, 2 years 8 months ago

MedMira Reports First Quarter Results FY2024
MedMira Inc. (TSXV:MIR) has reported its financial results for the quarter ended October 31, 2023. The company achieved significant milestones during this period, including receiving US FDA 510(k) clearance for the HIV-2 claim on its Reveal® G4 Rapid HIV 1/2 antibody test. This approval positions MedMira as a key player in the HIV testing market and allows the company to expand its market share and revenue in the United States.
PRESS RELEASE

published on 12/14/2023 at 04:30, 2 years 9 months ago

U.S. FDA Approves MedMira's Advanced Reveal G4 Rapid HIV-1/2 Antibody Test
PRESS RELEASE

published on 11/29/2023 at 05:00, 2 years 10 months ago

MedMira Reports FY2023 Fourth Quarter and Year End Financial Results
PRESS RELEASE

published on 09/28/2023 at 04:00, 3 years ago

Update on MedMira’s Regulatory Path in Canada and the USA
PRESS RELEASE

published on 08/31/2023 at 04:00, 3 years ago

Progress Update on Securities
PRESS RELEASE

published on 06/30/2023 at 04:00, 3 years 2 months ago

MedMira Reports Third Quarter Results FY2023
PRESS RELEASE

published on 04/04/2023 at 03:00, 3 years 5 months ago

MedMira Reports Second Quarter Results FY2023
PRESS RELEASE

published on 03/14/2023 at 21:31, 3 years 6 months ago

Update on MedMira’s Reveal TP (Syphilis) Clinical Trials in Canada
PRESS RELEASE

published on 02/20/2023 at 23:00, 3 years 7 months ago

MedMira Enters into Partnership with Maternova for USA and Latin America

Accesswire

Published on 09/29/2026 at 06:45, 2 hours 15 minutes ago

Akkodis and Biolevate Partner to Accelerate AI-Powered Scientific, Regulatory and Technical Documentation in Highly Regulated Industries
Published on 09/29/2026 at 04:36, 4 hours 24 minutes ago

The Next Decade of Medical AI: How Humans and AI Collaborate - A Conversation Between Kevin Kelly and Dr. Ning Song of Diagens Tech (2526. HK)
Published on 09/29/2026 at 02:30, 6 hours 30 minutes ago

QNX and neueHCT Join Forces to Accelerate Global Intelligent Driving Deployment, Anchored by Major German Automaker Program Win
Published on 09/29/2026 at 00:00, 9 hours ago

Medicure Announces Completion of Enrollment in Its MEND-PNPO Phase 3 Clinical Trial
Published on 09/28/2026 at 23:00, 10 hours ago

CORRECTION FROM SOURCE: Organto Foods Highlights Record First Half Results and Progress on Key Strategic Initiatives

View all ACCESSWIRE

EQS Group

Published on 09/29/2026 at 08:30, 30 minutes ago

2G Energy AG again secures orders exceeding EUR 400 million in the third quarter
Published on 09/29/2026 at 08:10, 49 minutes ago

Segway Powersports Brings Latin American and Canadian Media and Creators from Factory Floor to Real-World Terrain
Published on 09/29/2026 at 08:05, 54 minutes ago

EPAM Ranks #1 for Satisfaction and Delivery in 2026 Swiss Whitelane Research Study
Published on 09/29/2026 at 08:05, 54 minutes ago

One of Germany's Leading Veterinary Networks Chooses CoVet AI to Modernize Clinical Documentation
Published on 09/29/2026 at 08:00, 1 hour ago

Photon Energy N.V. Commissioned EY-P as an Independent Business Review Provider

Les Echos

Published on 09/29/2026 at 08:45, 15 minutes ago

Cegedim Santé réinvente l’accès à l’information médicale en déployant l’Assistant by Claude Bernard IA sur toutes ses solutions de médecine de ville
Published on 09/28/2026 at 17:54, 15 hours 5 minutes ago

Reporting on share buyback transactions carried out between September 21 and September 25, 2026
Published on 09/28/2026 at 17:54, 15 hours 5 minutes ago

Déclaration de rachats d'actions effectués par la Compagnie de Saint-Gobain entre le 21 et le 25 septembre 2026
Published on 09/28/2026 at 17:45, 15 hours 15 minutes ago

Weekly share buyback
Published on 09/28/2026 at 17:45, 15 hours 15 minutes ago

Déclaration hebdomadaire de rachat d'actions

View all LES ECHOS COMFI WIRE